Ultrasound‐guided foam sclerotherapy vs SFJ ligation and stripping (HL/S)
Complications (up to 8 years) · people with GSV incompetence
1 finding from 1 review
- no estimate extracted3 studies · 639 participantsVery low
Findings
What do systematic reviews say?
4,730 questions · 18,059 findings · 1,282 reviews
No studies found 4,360 · 24.1%GRADE not reported 2,529 · 14%Very low 4,641 · 25.7%Low 4,007 · 22.2%Moderate 2,057 · 11.4%High 465 · 2.6%
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Ultrasound‐guided foam sclerotherapy vs SFJ ligation and stripping (HL/S)
QoL · people with GSV incompetence
1 finding from 1 review
- no estimate extracted4 studies · 930 participantsModerate
Endovenous laser ablation (EVLA) vs radiofrequency ablation
Long‐term recurrence (> 5 years) · people with GSV incompetence
Endovenous laser ablation (EVLA) may leads to higher long‐term recurrence (> 5 years) compared with radiofrequency ablation (RFA) (low certainty).
1 finding from 1 review
- OR 2.77 [1.52, 5.06]1 study · 291 participantsLow
Endovenous laser ablation (EVLA) vs radiofrequency ablation
Complications (up to 8 years) · people with GSV incompetence
1 finding from 1 review
- no estimate extractedStudies not reportedVery low
Endovenous laser ablation (EVLA) vs radiofrequency ablation
QoL · people with GSV incompetence
1 finding from 1 review
- no estimate extractedStudies not reportedModerate
Endovenous laser ablation (EVLA) vs foam sclerotherapy
Technical success · people with GSV incompetence
Endovenous laser ablation (EVLA) showed no clear difference in technical success (< 5 years) compared with ultrasound‐guided foam sclerotherapy (UGFS) (low certainty).
2 findings from 1 review
- OR 6.13 [0.98, 38.27]3 studies · 588 participantsLow
- OR 6.47 [2.6, 16.1]3 studies · 534 participantsLow
Endovenous laser ablation (EVLA) vs foam sclerotherapy
Recurrence · people with GSV incompetence
It is very uncertain whether endovenous laser ablation (EVLA) changes recurrence (< 5 years) compared with ultrasound‐guided foam sclerotherapy (UGFS) (very low certainty).
1 finding from 1 review
- OR 0.68 [0.2, 2.36]2 studies · 443 participantsVery low
Nicotine replacement therapy vs placebo
Change in weight (kg) · People who have quit smoking
Nicotine replacement therapy for smoking cessation showed no clear difference in mean weight change (kg) at end of treatment compared with placebo (moderate certainty).
3 findings from 1 review
- Interventions for preventing weight gain after smoking cessation 2021 · Cochrane Headline outcomes onlyMD 0.5221 studies · 2784 participantsModerate
- Interventions for preventing weight gain after smoking cessation 2021 · Cochrane Headline outcomes onlyMD 0.0811 studies · 1021 participantsModerate
- Interventions for preventing weight gain after smoking cessation 2021 · Cochrane Headline outcomes onlyMD 0.3717 studies · 1463 participantsModerate
Varenicline vs placebo
Change in weight (kg) · People who have quit smoking
Varenicline for smoking cessation showed no clear difference in mean weight change (kg) at end of treatment compared with placebo (high certainty).
3 findings from 1 review
- Interventions for preventing weight gain after smoking cessation 2021 · Cochrane Headline outcomes onlyMD 0.2314 studies · 2566 participantsHigh
- Interventions for preventing weight gain after smoking cessation 2021 · Cochrane Headline outcomes onlyMD 0.093 studies · 384 participantsLow
- Interventions for preventing weight gain after smoking cessation 2021 · Cochrane Headline outcomes onlyMD 1.053 studies · 237 participantsLow
Fluoexetine vs placebo
Change in weight (kg) · People who have quit smoking
Fluoexetine showed no clear difference in mean weight change (kg) at end of treatment compared with placebo (low certainty).
2 findings from 1 review
- Interventions for preventing weight gain after smoking cessation 2021 · Cochrane Headline outcomes onlyMD 1.012 studies · 144 participantsLow
- Interventions for preventing weight gain after smoking cessation 2021 · Cochrane Headline outcomes onlyMD 1.012 studies · 124 participantsVery low
Intervention not reported
Clinical outcomes · Adults with multimorbidity (two or more chronic conditions)
1 finding from 1 review
- Interventions for improving outcomes in patients with multimorbidity in primary care and community settings 2021 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedModerate
Intervention not reported
Mental health outcomes · Adults with multimorbidity (two or more chronic conditions)
1 finding from 1 review
- Interventions for improving outcomes in patients with multimorbidity in primary care and community settings 2021 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedHigh
Intervention not reported
Patient‐reported outcome measures (PROMs) · Adults with multimorbidity (two or more chronic conditions)
1 finding from 1 review
- Interventions for improving outcomes in patients with multimorbidity in primary care and community settings 2021 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedModerate
Intervention not reported
Health Service Utilisation · Adults with multimorbidity (two or more chronic conditions)
1 finding from 1 review
- Interventions for improving outcomes in patients with multimorbidity in primary care and community settings 2021 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedLow
Intervention not reported
Medication use and adherence · Adults with multimorbidity (two or more chronic conditions)
1 finding from 1 review
- Interventions for improving outcomes in patients with multimorbidity in primary care and community settings 2021 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedLow
Intervention not reported
Health‐related patient behaviours · Adults with multimorbidity (two or more chronic conditions)
1 finding from 1 review
- Interventions for improving outcomes in patients with multimorbidity in primary care and community settings 2021 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedModerate
Intervention not reported
Provider behaviour · Adults with multimorbidity (two or more chronic conditions)
1 finding from 1 review
- Interventions for improving outcomes in patients with multimorbidity in primary care and community settings 2021 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedModerate
Surgery for Bell's palsy vs medical treatment (oral prednisolone) or no treatment
Complete recovery of facial nerve function at 12 months Defined as: complete recovery HB grade I. · Bell's palsy
It is very uncertain whether surgery for Bell's palsy changes complete recovery of facial nerve function at 12 months Defined as:… compared with medical treatment (oral prednisolone) or no treatment (very low certainty).
1 finding from 1 review
- Surgical interventions for the early management of Bell's palsy 2021 · Cochrane Headline outcomes onlyRR 0.762 studies · 57 participantsVery low
Surgery for Bell's palsy vs medical treatment (oral prednisolone) or no treatment
Complications and side effects · Bell's palsy
It is very uncertain whether surgery for Bell's palsy changes side effects and complications of treatmentMeasured by clinical… compared with medical treatment (oral prednisolone) or no treatment (very low certainty).
1 finding from 1 review
- Surgical interventions for the early management of Bell's palsy 2021 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 57 participantsVery low
Early surgery vs late surgery
Complete recovery of facial nerve function at 12 months Defined as: complete recovery HB grade I. · Bell's palsy
It is very uncertain whether early surgery changes complete recovery of facial nerve function at 12 months Defined as:… compared with late surgery (very low certainty).
1 finding from 1 review
- Surgical interventions for the early management of Bell's palsy 2021 · Cochrane Headline outcomes onlyRR 0.47 [0.03, 6.6]1 study · 26 participantsVery low